- 現金殖利率: 2.8%、總殖利率: 10.0%、5年平均現金配發率: 39.67%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 1.66 | 2.47 | 0.85 | 41.67 | 0.80 | -20.0 | 51.20 | 38.25 | 48.19 | -21.93 | 99.40 | 0.64 |
| 2024 (4) | 1.62 | 0.62 | 0.60 | 0.0 | 1.00 | 0.0 | 37.04 | -0.62 | 61.73 | -0.62 | 98.77 | -0.62 |
| 2023 (3) | 1.61 | -34.29 | 0.60 | 7.14 | 1.00 | 7.53 | 37.27 | 63.04 | 62.11 | 63.63 | 99.38 | 63.41 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 0.38 | 0.0 | -20.83 | 0.38 | 0.0 | -13.64 | 0.38 | -77.11 | -20.83 |
| 25Q4 (7) | 0.38 | -7.32 | 15.15 | 0.38 | 11.76 | -7.32 | 1.66 | 29.69 | 1.84 |
| 25Q3 (6) | 0.41 | -6.82 | 5.13 | 0.34 | -22.73 | -10.53 | 1.28 | 47.13 | -1.54 |
| 25Q2 (5) | 0.44 | -8.33 | -16.98 | 0.44 | 0.0 | 12.82 | 0.87 | 81.25 | -13.0 |
| 25Q1 (4) | 0.48 | 45.45 | 0.0 | 0.44 | 7.32 | 0.0 | 0.48 | -70.55 | 0.0 |
| 24Q4 (3) | 0.33 | -15.38 | 0.0 | 0.41 | 7.89 | 0.0 | 1.63 | 25.38 | 0.0 |
| 24Q3 (2) | 0.39 | -26.42 | 0.0 | 0.38 | -2.56 | 0.0 | 1.30 | 30.0 | 0.0 |
| 24Q2 (1) | 0.53 | 0.0 | 0.0 | 0.39 | 0.0 | 0.0 | 1.00 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 5.7 | 1.38 | 13.52 | 21.98 | 12.43 | 15.63 | N/A | - | ||
| 2026/3 | 5.63 | 30.75 | 17.27 | 16.28 | 12.05 | 16.28 | 1.35 | - | ||
| 2026/2 | 4.3 | -32.23 | -7.8 | 10.65 | 9.47 | 16.09 | 1.37 | - | ||
| 2026/1 | 6.35 | 16.76 | 25.41 | 6.35 | 25.41 | 16.81 | 1.31 | - | ||
| 2025/12 | 5.44 | 8.17 | 4.33 | 61.89 | 11.27 | 15.89 | 1.38 | - | ||
| 2025/11 | 5.03 | -7.43 | 0.9 | 56.45 | 11.99 | 15.84 | 1.38 | - | ||
| 2025/10 | 5.43 | 0.82 | 9.2 | 51.42 | 13.2 | 15.85 | 1.38 | - | ||
| 2025/9 | 5.39 | 7.02 | 21.72 | 45.99 | 13.7 | 15.37 | 1.37 | - | ||
| 2025/8 | 5.03 | 1.56 | 1.99 | 40.61 | 12.71 | 15.73 | 1.34 | - | ||
| 2025/7 | 4.95 | -13.77 | 1.31 | 35.57 | 14.41 | 16.02 | 1.32 | - | ||
| 2025/6 | 5.75 | 7.98 | 51.46 | 30.62 | 16.86 | 16.09 | 1.26 | 係因子公司認列產品研究服務收入款項 | ||
| 2025/5 | 5.32 | 5.9 | 10.16 | 24.87 | 11.0 | 15.14 | 1.34 | - | ||
| 2025/4 | 5.02 | 4.74 | 6.62 | 19.55 | 11.23 | 14.49 | 1.4 | - | ||
| 2025/3 | 4.8 | 2.78 | 14.85 | 14.53 | 12.92 | 14.53 | 1.28 | - | ||
| 2025/2 | 4.67 | -7.81 | 62.27 | 9.73 | 11.99 | 14.94 | 1.24 | 主因二期春節期間不同，導致去年同期基期較低，致今年成長幅度提升。 | ||
| 2025/1 | 5.06 | -2.85 | -12.88 | 5.06 | -12.88 | 15.26 | 1.22 | - | ||
| 2024/12 | 5.21 | 4.61 | 20.13 | 55.61 | 8.64 | 15.17 | 1.12 | - | ||
| 2024/11 | 4.98 | 0.17 | 12.22 | 50.4 | 7.58 | 14.38 | 1.19 | - | ||
| 2024/10 | 4.97 | 12.37 | 10.12 | 45.42 | 7.09 | 14.33 | 1.19 | - | ||
| 2024/9 | 4.42 | -10.32 | 14.13 | 40.45 | 6.73 | 14.25 | 1.21 | - | ||
| 2024/8 | 4.93 | 0.88 | 17.48 | 36.03 | 5.89 | 13.62 | 1.27 | - | ||
| 2024/7 | 4.89 | 28.9 | 16.12 | 31.09 | 4.25 | 13.51 | 1.28 | - | ||
| 2024/6 | 3.79 | -21.45 | -16.55 | 26.2 | 2.3 | 13.34 | 1.24 | - | ||
| 2024/5 | 4.83 | 2.5 | 6.28 | 22.41 | 6.37 | 13.72 | 1.2 | - | ||
| 2024/4 | 4.71 | 12.82 | 17.29 | 17.58 | 6.4 | 11.76 | 1.4 | - | ||
| 2024/3 | 4.18 | 45.22 | -13.14 | 12.86 | 2.9 | 12.86 | N/A | - | ||
| 2024/2 | 2.88 | -50.51 | -17.06 | 8.69 | 12.94 | 13.03 | N/A | - | ||
| 2024/1 | 5.81 | 33.96 | 37.57 | 5.81 | 37.57 | 14.59 | N/A | - | ||
| 2023/12 | 4.34 | -2.27 | -6.25 | 51.19 | 16.47 | 13.29 | N/A | - | ||
| 2023/11 | 4.44 | -1.69 | 10.69 | 46.85 | 19.14 | 12.83 | N/A | - | ||
| 2023/10 | 4.52 | 16.46 | 12.83 | 42.41 | 20.1 | 12.59 | N/A | - | ||
| 2023/9 | 3.88 | -7.68 | 2.61 | 37.9 | 21.03 | 12.29 | N/A | - | ||
| 2023/8 | 4.2 | -0.28 | 12.58 | 34.02 | 23.55 | 12.96 | N/A | - | ||
| 2023/7 | 4.21 | -7.36 | 18.77 | 29.82 | 25.27 | 13.3 | N/A | - | ||
| 2023/6 | 4.55 | 0.03 | 35.45 | 25.61 | 26.41 | 13.11 | N/A | - | ||
| 2023/5 | 4.54 | 13.12 | 17.08 | 21.06 | 24.62 | 13.37 | N/A | - | ||
| 2023/4 | 4.02 | -16.45 | 20.05 | 16.52 | 26.87 | 12.29 | N/A | - | ||
| 2023/3 | 4.81 | 38.67 | 41.65 | 12.5 | 29.22 | 12.5 | N/A | - | ||
| 2023/2 | 3.47 | -17.9 | 39.54 | 7.69 | 22.51 | 12.32 | N/A | - | ||
| 2023/1 | 4.22 | -8.71 | 11.35 | 4.22 | 11.35 | 12.86 | N/A | - | ||
| 2022/12 | 4.63 | 15.39 | 38.84 | 43.95 | 35.69 | 12.64 | N/A | - | ||
| 2022/11 | 4.01 | 0.2 | 31.63 | 39.32 | 35.32 | 11.79 | N/A | - | ||
| 2022/10 | 4.0 | 5.92 | 41.87 | 35.31 | 35.76 | 11.51 | N/A | - | ||
| 2022/9 | 3.78 | 1.27 | 38.77 | 31.31 | 35.01 | 11.05 | N/A | - | ||
| 2022/8 | 3.73 | 5.19 | 44.09 | 27.53 | 34.51 | 10.63 | N/A | - | ||
| 2022/7 | 3.55 | 5.64 | 44.26 | 23.8 | 33.13 | 10.78 | N/A | - | ||
| 2022/6 | 3.36 | -13.52 | 29.34 | 20.26 | 31.35 | 10.58 | N/A | - | ||
| 2022/5 | 3.88 | 15.98 | 44.53 | 16.9 | 31.76 | 10.62 | N/A | - | ||
| 2022/4 | 3.35 | -1.42 | 33.74 | 13.02 | 28.38 | 9.23 | N/A | - | ||
| 2022/3 | 3.39 | 36.6 | 27.31 | 9.67 | 26.62 | 9.67 | N/A | - | ||
| 2022/2 | 2.49 | -34.48 | 28.03 | 6.28 | 26.26 | 9.61 | N/A | - | ||
| 2022/1 | 3.79 | 13.82 | 25.12 | 3.79 | 25.12 | 10.17 | N/A | - | ||
| 2021/12 | 3.33 | 9.4 | 17.7 | 32.39 | 6.62 | 9.2 | N/A | - | ||
| 2021/11 | 3.05 | 7.99 | 16.61 | 29.06 | 5.48 | 8.59 | N/A | - | ||
| 2021/10 | 2.82 | 3.61 | 0.63 | 26.01 | 4.32 | 8.13 | N/A | - | ||
| 2021/9 | 2.72 | 5.15 | 19.43 | 23.19 | 4.78 | 7.77 | N/A | - | ||
| 2021/8 | 2.59 | 5.32 | 5.34 | 20.47 | 3.1 | 7.64 | N/A | - | ||
| 2021/7 | 2.46 | -5.28 | -8.8 | 17.88 | 2.78 | 7.74 | N/A | - | ||
| 2021/6 | 2.6 | -3.37 | 14.82 | 15.42 | 4.91 | 0.0 | N/A | - | ||
| 2021/5 | 2.69 | 7.33 | 25.62 | 12.83 | 3.11 | 0.0 | N/A | - |